Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JT3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,636
Award facts
- Contract value 100% obligated
- $87,635.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $87,635.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on January 5, 2026, with an ultimate completion date of January 6, 2026. This is a firm fixed price, non-set-aside contract with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies critical medical commodities to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military medical programs. The company's contract portfolio demonstrates extensive experience fulfilling federal pharmaceutical procurement requirements through competitive awards, with products spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies. This specific award for Dupixent, a biologic treatment for dermatological and respiratory conditions, reflects the company's capability to deliver specialized pharmaceutical products to support military healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F9JT3?
SPE2DR26F9JT3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F9JT3 worth?
The government has obligated $87,636 on SPE2DR26F9JT3.
Is contract SPE2DR26F9JT3 an order under another contract?
Yes. SPE2DR26F9JT3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JT3 competed?
The extent of competition for SPE2DR26F9JT3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award